HIV/AIDS
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All adults diagnosed with HIV infection who are receiving ART and have a follow-up period of six months or more, along with a poor virological outcome, will qualify to participate in the intervention
Exclusion criteria
Exclusion criteria: Conversely, adult patients with HIV-HBV co-infected who have been followed for less than six months, are unable to communicate, suffer from hearing loss, are critically ill, have other co-infections or comorbidities, experience immune suppression, exhibit extrahepatic manifestations, have a family history of liver cancer or cirrhosis, or are pregnant, will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Virological Suppression Clinical outcomes will be evaluated based on the HIV viral load assessed at baseline and at the conclusion of treatment, which occurs 6-month post-treatment (VS). A viral load of less than often = 1,000 copies/Ml at 6 months following the end of treatment will be deemed classified as virological suppression. Information will be gathered from the medical records of patients as well as the findings from viral load machines regarding this parameter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication Adherence | — |
Countries
Ethiopia
Contacts
Ethiopian Federal Ministry of Health